SEC Form 4 · accession 0001179110-15-008147
PTC THERAPEUTICS, INC. · PTCT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael Schmertzler
Director
Period of report
May 15, 2015
Accepted (ET)
May 19, 2015 · 8:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070081
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | May 15, 2015 | J | 733 | — | D | 2,988 | I | See footnote |
| Common StockF4,F5 | May 18, 2015 | J | 2,852 | — | D | 136 | I | See footnote |
| Common StockF6 | May 19, 2015 | J | 136 | — | D | 0 | I | See footnote |
| Common StockF1 | holding | — | — | — | 26,766 | D | ||
| Common StockF7 | holding | — | — | — | 1,320,369 | I | See footnote |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $51.00 | holding | — | — | — | Jan 2, 2016 | Jan 1, 2025 | Common Stock | 24,000 | 24,000 | D |
| Stock Option (Right to Buy) | $27.05 | holding | — | — | — | Jan 28, 2015 | Jan 27, 2024 | Common Stock | 20,000 | 20,000 | D |
| Stock Option (Right to Buy)F8 | $10.85 | holding | — | — | — | — | May 15, 2023 | Common Stock | 60,000 | 60,000 | D |
| Stock Option (Right to Buy)F9 | $218.40 | holding | — | — | — | — | Jan 10, 2022 | Common Stock | 276 | 276 | D |
| Stock Option (Right to Buy)F9 | $490.80 | holding | — | — | — | — | Apr 27, 2021 | Common Stock | 276 | 276 | D |
| Stock Option (Right to Buy)F9 | $1,149.60 | holding | — | — | — | — | Feb 2, 2020 | Common Stock | 216 | 216 | D |
| Stock Option (Right to Buy)F9 | $508.80 | holding | — | — | — | — | Oct 7, 2019 | Common Stock | 266 | 266 | D |
| Stock Option (Right to Buy)F9 | $735.60 | holding | — | — | — | — | Jan 25, 2018 | Common Stock | 166 | 166 | D |
| Stock Option (Right to Buy)F9 | $735.60 | holding | — | — | — | — | Jul 14, 2018 | Common Stock | 83 | 83 | D |
| Stock Option (Right to Buy)F9 | $626.40 | holding | — | — | — | — | Apr 18, 2017 | Common Stock | 125 | 125 | D |
| Stock Option (Right to Buy)F9 | $392.40 | holding | — | — | — | — | Mar 1, 2016 | Common Stock | 90 | 90 | D |
Explanation of responses
- F1Represents 26,766 shares of common stock of the Issuer ("common stock") directly held by the reporting person.
- F2Represents dispositions pursuant to Rule 144 of (i) 687 shares of common stock held by EMA Private Equity Fund 1999 LP and (ii) 46 shares of common stock held by Credit Suisse First Boston Finders and Screeners LP at a weighted average price of $52.8576 per share. Although included in the reporting person's prior ownership reports, the reporting person disclaims beneficial ownership of the disposed securities.
- F3Consists of (i) 2,800 shares held by EMA Private Equity Fund 1999 LP and (ii) 188 shares held by Credit Suisse First Boston Finders and Screeners LP. The reporting person is a managing director of Aries Advisors, LLC, the sub-advisor to Credit Suisse First Boston Equity Partners, L.P. The reporting person disclaims beneficial ownership of the shares of common stock held by these entities.
- F4Represents dispositions pursuant to Rule 144 of (i) 2,673 shares of common stock held by EMA Private Equity Fund 1999 LP and (ii) 179 shares of common stock held by Credit Suisse First Boston Finders and Screeners LP at a weighted average price of $53.1517 per share. Although included in the reporting person's prior ownership reports, the reporting person disclaims beneficial ownership of the disposed securities.
- F5Consists of (i) 127 shares held by EMA Private Equity Fund 1999 LP and (ii) 9 shares held by Credit Suisse First Boston Finders and Screeners LP. The reporting person disclaims beneficial ownership of the shares of common stock held by these entities.
- F6Represents dispositions pursuant to Rule 144 of (i) 127 shares of common stock held by EMA Private Equity Fund 1999 LP and (ii) 9 shares of common stock held by Credit Suisse First Boston Finders and Screeners LP at a weighted average price of $51.9676 per share. Although included in the reporting person's prior ownership reports, the reporting person disclaims beneficial ownership of the disposed securities.
- F7Represents shares of common stock held by Section Six Partners, L.P. The reporting person is a general and limited partner of, and trustee of certain family trusts holding interests in, Section Six Partners, L.P. The reporting person disclaims beneficial ownership of the shares of common stock held by Section Six Partners, L.P. except to the extent of his pecuniary interest therein.
- F8This option was granted on May 15, 2013 and vests over three years, with 8.33% of the shares underlying the option vested on August 15, 2013 and an additional 8.33% of the original number of shares underlying the option vesting at the end of each successive three-month period thereafter.
- F9Currently exercisable.